The estimated Net Worth of Jared Watkin is at least $21.5 Milión dollars as of 28 February 2023. Mr. Watkin owns over 1,198 units of Abbott Laboratories stock worth over $8,321,276 and over the last 9 years he sold ABT stock worth over $13,147,047. In addition, he makes $0 as Senior Vice President - Diabetes Care at Abbott Laboratories.
Jared has made over 20 trades of the Abbott Laboratories stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 1,198 units of ABT stock worth $120,639 on 28 February 2023.
The largest trade he's ever made was exercising 309,429 units of Abbott Laboratories stock on 2 May 2019 worth over $14,289,431. On average, Jared trades about 18,268 units every 95 days since 2015. As of 28 February 2023 he still owns at least 71,366 units of Abbott Laboratories stock.
You can see the complete history of Mr. Watkin stock trades at the bottom of the page.
Jared L. Watkin serves as Senior Vice President - Diabetes Care of the Company. Between 2010 to 2015 Divisional Vice President, Technical Operations, Diabetes Care. Elected as Corporate Officer in 2015.
Jared Watkin is 52, he's been the Senior Vice President - Diabetes Care of Abbott Laboratories since 2015. There are 31 older and 11 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
Jared's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez a Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: